ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,268Medicare Part D Prescriptions Filled, Including Refills

Rank: 108 out of 783

$725K Total Retail Price of All Prescriptions

Rank: 125 out of 783

345 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
90% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 345 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

25% of this provider’s 345 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 11,487 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
DONEPEZIL HCL 497 491 1 24
FUROSEMIDE 466 449 2 7
HYDROCODONE-ACETAMINOPHEN 441 362 S3 3 2
LEVOTHYROXINE SODIUM 432 396 4 1
LISINOPRIL 418 371 5 4
SIMVASTATIN 339 302 6 3
AMLODIPINE BESYLATE 330 305 7 5
METOPROLOL TARTRATE 316 259 8 9
LANTUS 315 250 9 38
OMEPRAZOLE 303 250 10 6
WARFARIN SODIUM 299 260 11 10
POTASSIUM CHLORIDE 274 249 12 16
GABAPENTIN 261 222 13 15
NAMENDA 258 245 14 32
DIVALPROEX SODIUM 242 222 15 72
CYMBALTA 204 142 16 35
CITALOPRAM HBR 204 197 16 19
NOVOLOG 190 150 18 81
SERTRALINE HCL 189 171 19 22
MIRTAZAPINE 164 139 20 52
POLYETHYLENE GLYCOL 3350 162 145 21 43
RISPERIDONE 149 127 22 67
METOPROLOL SUCCINATE 142 140 23 13
TRAZODONE HCL 129 101 24 39
QUETIAPINE FUMARATE 127 117 25 79
RANITIDINE HCL 125 106 26 44
ALLOPURINOL 122 121 27 31
TAMSULOSIN HCL 121 100 28 26
FLUOXETINE HCL 114 61 29 45
LEVETIRACETAM 111 73 30 89
DIGOXIN 97 96 31 61
ISOSORBIDE MONONITRATE ER 89 84 32 40
CARVEDILOL 88 80 33 21
CLONIDINE HCL 82 79 34 60
CEPHALEXIN 82 77 34 70
TRAMADOL HCL 78 74 36 20
OLANZAPINE 76 57 37 108
HUMALOG 75 59 38 101
METFORMIN HCL 71 68 39 8
SANTYL 68 60 40 197
ROPINIROLE HCL 67 67 41 74
ALENDRONATE SODIUM 66 66 42 25
SULFAMETHOXAZOLE-TRIMETHOPRIM 66 57 42 95
RIVASTIGMINE 63 63 44 249
CIPROFLOXACIN HCL 63 56 44 62
CARBIDOPA-LEVODOPA 62 62 46 88
PREDNISONE 59 55 47 36
SEROQUEL 58 58 48 183
DETROL LA 58 43 48 220
AMOX TR-POTASSIUM CLAVULANATE 57 43 50 128
LIDODERM 56 52 51 132
ATORVASTATIN CALCIUM 56 49 51 11
METOCLOPRAMIDE HCL 55 39 53 121
DILTIAZEM 24HR CD 55 55 53 118
ATENOLOL 54 50 55 17
ESCITALOPRAM OXALATE 54 54 55 54
PRIMIDONE 53 53 57 230
FLUTICASONE PROPIONATE 53 41 57 46
HYDRALAZINE HCL 52 51 59 78
LOSARTAN POTASSIUM 51 50 60 18
CLOPIDOGREL 50 42 61 29
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 8, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.